In an assay of serum samples from healthy donors and patients with ER-positive breast cancer or TNBC, the level of soluble GFRA1 was similarly low between serum from patients with breast cancer and that from healthy donors (Figure 3E). This evidence concerns the gene GFRA1 and breast carcinoma.